US 10653743
Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
granted A61KA61K31/54A61K38/08
Quick answer
US patent 10653743 (Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/54, A61K38/08, A61K38/10, A61K38/12